Cargando…
Treatment of malignant pericardial effusion with (32)P-colloid
Malignant pericardial effusion is usually treated only when signs of cardiac tamponade develop. Several methods of treatment have been reported with an overall response rate of approximately 75%. Since our initial study using intrapericardial (32)P-colloid instillation as a treatment modality for pe...
Autores principales: | Dempke, W, Firusian, N |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1999
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2363149/ https://www.ncbi.nlm.nih.gov/pubmed/10471044 http://dx.doi.org/10.1038/sj.bjc.6690625 |
Ejemplares similares
-
Management of Malignant Pericardial Effusion
por: Petrofsky, Mary
Publicado: (2014) -
Controlling malignant pericardial effusion by intrapericardial carboplatin administration in patients with primaryon-small-cell lung cancer
por: Moriya, T, et al.
Publicado: (2000) -
The Prognostic Impact of Pericardial Fluid Cytology in Malignant Pericardial Effusion
por: Sezenöz, Burak, et al.
Publicado: (2023) -
Malignant pericardial effusion: sclerotherapy or local chemotherapy?
por: Lestuzzi, C, et al.
Publicado: (2009) -
Survival post surgery for malignant pericardial effusion
por: Nguyen, Olivier, et al.
Publicado: (2011)